Thursday, October 10, 2019 3:06:12 AM
Fragrance Group Limited (FGL) is an investment holding company. The Company is a property developer with presence in Asia, Australia and Europe. It segments include Property development, which is involved in the development and sale of residential and commercial properties, and Property investment, which is involved in investing in properties for rental yield and capital appreciation. FGL's development projects comprise residential, commercial, hotel and industrial properties, with over 80 projects. Its overseas development properties include its maiden project, Premier Tower, a skyscraper mixed-use development located in Melbourne, Australia, and NV Apartments, freehold apartments located in the Central Business District of Perth, Western Australia. FGL's property investment portfolio includes prime commercial properties situated in and near Singapore's Central Business District (CBD) and a seafront food and beverage outlets and an industrial building.
Recent BCRD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 10:25:46 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/14/2024 10:21:12 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 01/29/2024 03:16:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 10:00:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:12:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 07:35:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:30:29 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 06:45:29 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/29/2023 08:13:41 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM